Prostate cancer drugs taken by thousands of men can cause depression, say scientists.
A new Boston-based study published in the Journal of Clinical Oncology reveals a direct link between low-mood and testosterone-reducing therapies (ADT).
In addition, it suggests such medical interventions also double the risk of Alzheimer’s disease.
Read more of the original article from DailyMail.
